Total Payments
$1.8M
2024 Payments
$274,792
Companies
19
Transactions
2,343
Payment Breakdown by Category
Other$1.6M (85.9%)
Travel$133,078 (7.3%)
Consulting$84,715 (4.7%)
Food & Beverage$37,718 (2.1%)
Education$84.65 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.6M | 669 | 85.8% |
| Travel and Lodging | $133,078 | 793 | 7.3% |
| Consulting Fee | $84,715 | 33 | 4.7% |
| Food and Beverage | $37,718 | 840 | 2.1% |
| Honoraria | $2,000 | 1 | 0.1% |
| Education | $84.65 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $602,039 | 750 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $562,542 | 756 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $159,267 | 221 | $0 (2024) |
| ITI, Inc. | $153,261 | 164 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $111,569 | 129 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $87,869 | 122 | $0 (2020) |
| Axsome Therapeutics, Inc. | $43,493 | 53 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $31,400 | 47 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28,747 | 33 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $15,300 | 21 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $274,792 | 305 | Otsuka America Pharmaceutical, Inc. ($91,629) |
| 2023 | $318,554 | 357 | Otsuka America Pharmaceutical, Inc. ($80,859) |
| 2022 | $270,871 | 325 | Alkermes, Inc. ($75,591) |
| 2021 | $185,063 | 194 | Otsuka America Pharmaceutical, Inc. ($67,285) |
| 2020 | $110,106 | 154 | Alkermes, Inc. ($60,271) |
| 2019 | $205,078 | 340 | Alkermes, Inc. ($101,228) |
| 2018 | $231,253 | 345 | Alkermes, Inc. ($92,310) |
| 2017 | $218,598 | 323 | Alkermes, Inc. ($99,647) |
All Payment Transactions
2,343 individual payment records from CMS Open Payments — Page 1 of 94
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $460.00 | General |
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $105.89 | General |
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $87.60 | General |
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.29 | General |
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,724.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | Cash or cash equivalent | $127.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $5,980.00 | General |
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Neuroscience | ||||||
| 12/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $187.60 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $110.17 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $120.60 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $115.71 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,724.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $118.42 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $100.50 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.66 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $73.70 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Carmen Pinto, M.D
Dr. Carmen Pinto, M.D is a Psychiatry healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306887500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carmen Pinto, M.D has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $274,792 received in 2024. These payments were reported across 2,343 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.6M).
Ad
Practice Information
- Specialty Psychiatry
- Location Elizabethtown, KY
- Active Since 06/09/2006
- Last Updated 07/09/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1306887500
Products in Payments
- REXULTI (Drug) $358,330
- ARISTADA (Drug) $310,577
- ABILIFY MAINTENA (Drug) $195,854
- Aristada 441 mg (Drug) $191,958
- CAPLYTA (Drug) $182,008
- INVEGA SUSTENNA (Drug) $136,285
- INGREZZA (Drug) $111,569
- LYBALVI (Drug) $99,505
- LATUDA (Drug) $87,869
- Auvelity (Drug) $43,493
- FANAPT (Drug) $31,375
- INVEGA TRINZA (Drug) $23,458
- Trintellix (Drug) $20,235
- ABILIFY ASIMTUFII (Drug) $12,378
- UZEDY (Drug) $1,225
- Entyvio (Biological) $196.20
- INVEGA (Drug) $149.43
- VYVANSE (Drug) $15.00
- HETLIOZ (Drug) $12.63
- VRAYLAR (Drug) $12.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Elizabethtown
Dr. Imran Iqbal, M.d, M.D
Psychiatry — Payments: $6,275
Psychiatry $6,275
Suresh Kodali, M.d, M.D
Psychiatry — Payments: $5,793
Psychiatry $5,793
Mr. Tyler De Witt, Md, MD
Psychiatry — Payments: $3,234
Psychiatry $3,234
Navinchandra Shah, M.d, M.D
Psychiatry — Payments: $261.71
Psychiatry $261.71
Thomas Brown, Md, MD
Psychiatry — Payments: $53.82
Psychiatry $53.82
Kausar Chaudhry, Md, MD
Psychiatry
Psychiatry